2011 to 2022 Saw Increase in Autism Diagnoses Among Children, Adults

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

THURSDAY, Oct. 31, 2024 -- From 2011 to 2022, there was an increase in autism spectrum disorder (ASD) diagnoses among children and adults, according to a study published online Oct. 30 in JAMA Network Open.

Luke P. Grosvenor, Ph.D., from Kaiser Permanente Northern California in Pleasanton, and colleagues examined trends in the prevalence of ASD diagnoses using electronic records data from a large network of health systems in the United States in a cross-sectional study conducted from Jan. 1, 2011, to Dec. 31, 2022.

Overall, 12,264,003 members were enrolled in 2022 (19.2 percent children aged 0 to 17 years). The researchers found that throughout the study period, the ASD diagnosis rate was highest among 5- to 8-year-olds, and increased by 175 percent among the full sample, from 2.3 to 6.3 per 1,000 in 2011 and 2022, respectively. From 2011 to 2022, the greatest relative increase in diagnosis rate occurred among 26- to 34-year-olds (450 percent); greater increases were seen for female versus male children (305 versus 185 percent) and female versus male adults (315 versus 215 percent, respectively). Among children, but not adults, racial and ethnic minority groups had greater relative increases compared with White individuals.

"These findings forecast a substantial number of autistic people aging into adult care and can be used both to inform interventions for addressing disparities and to efficiently allocate resources to meet the support needs of autistic people across the lifespan," the authors write.

One author disclosed ties to SAGE Pharmaceuticals.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-11-01 12:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords

AI Assitant